Abstract: A mask includes an opening area and a shelter area adjacent to the opening area, the opening area includes an opening pattern, the shelter area includes a buffer pattern adapted to the opening pattern. This application achieves a purpose that a sudden change of stress at a boundary between the opening area and the shelter area is buffered, thereby ensuring that the pull of the mesh as it opens may be smoothly transmitted from the shelter area to the opening area. In addition, this application may also effectively improve meshing accuracy of the mask, thereby improving a yield of vapor deposition products.

Abstract: A route advertisement method is applied to a network in which a cross-domain end-to-end tunnel carries a service. The cross-domain end-to-end tunnel crosses at least two Interior Gateway Protocol (IGP) network domains, and the at least two IGP network domains include a first network device, a second network device, and a third network device. The route advertisement method includes receiving, by the first network device, Border Gateway Protocol (BGP) service routing information from the second network device, where the BGP service routing information includes a destination address and a next-hop address to the destination address, skipping, by the first network device, performing route recursion on the next-hop address, and advertising, by the first network device, the BGP service routing information to the third network device.

Abstract: A route recursion control method includes a first network device that receives Border Gateway Protocol (BGP) routing information from a second network device. The BGP routing information includes a destination address, a next-hop address for the destination address, and attribute information. The attribute information indicates a manner of performing route recursion on the next-hop address by the first network device. The first network device determines, based on the attribute information, the manner of performing the route recursion on the next-hop address.

Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.

Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.

Abstract: A battery charger controller is configured to add a compensation current in the feedback control loop such that the output voltage varies with the output current to compensate charging cable voltage drop. In some embodiments, the output voltage is also proportional to a compensation resistor. Therefore, cable voltage drop compensation can be adjusted using a resistor that is external to the controller IC. The external resistor may be one of the feedback resistors connected at a voltage feedback pin. In another embodiment, the adjustable resistor is the resistor between the feedback resistors and the voltage feedback pin. In still another embodiment, the adjustable resistor is the resistor in parallel with a compensation capacitor. In embodiments of the invention, adjusting the resistance of the external compensation resistor can change the voltage drop compensation and allow the power supply to meet requirements of different charging cable applications.

Abstract: Provided is a vehicle measurement system for an automatic conveyor. The measurement system includes: an information measurement unit, disposed at a position higher than the ready-for-loading vehicle and including two laser radars: a rear radar and a side radar; a voice prompt unit, configured to send a voice prompt; and a control unit; where when the ready-for-loading vehicle is approaching, the rear radar measures a distance between it and the ready-for-loading vehicle in real time as a predetermined parking distance; when a value of the predetermined parking distance is within a predetermined range, the control unit controls the voice prompt unit to send a voice prompt for parking; and after the ready-for-loading vehicle stops, the information measurement unit measures the distance between the ready-for-loading vehicle and the rear radar, carriage size information, and a deviation angle of a parking position of the ready-for-loading vehicle from the predetermined parking area.

Abstract: Provided herein are Heteroaryl Compounds having the following structure: wherein R1-R4 are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, neurodegenerative diseases, diabetes, obesity, neurological disorders, age-related diseases, or cardiovascular conditions, comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.

Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.

Abstract: Provided herein are Heteroaryl Compounds having the following structure: wherein R1-R4 are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, neurodegenerative diseases, diabetes, obesity, neurological disorders, age-related diseases, or cardiovascular conditions, comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.

Abstract: The application relates to a mask and a vapor deposition device. The mask includes a first region provided with a first plurality of openings; and second regions located at both sides of the first region along a predetermined direction. At least one of the second regions is provided with a third plurality of openings disposed adjacent to the first plurality of openings and having a same structure as the first plurality of openings. At least a part of the first plurality of openings are used to form a first type of sub-pixels when the mask is in a first state. The first plurality of openings and at least a part of the third plurality of openings are used together to form a type of sub-pixels different from the first type of sub-pixels, when the mask moves a predetermined distance along the predetermined direction to be in a second state.

Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.

Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.

Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.

Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.

Abstract: Provided herein are Heteroaryl Compounds having the following structure: wherein R1-R4 are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, neurodegenerative diseases, diabetes, obesity, neurological disorders, age-related diseases, or cardiovascular conditions, comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.

Abstract: Provided herein are methods for the preparation of substituted pyrazino[2,3-b]pyrazines of the formula (II): the method comprising contacting a compound of formula (VI): with R1—Y in a solvent, in the presence of a palladium catalyst, wherein said contacting occurs in the presence of a base, wherein R1-R3, Y, the palladium catalyst and the base are as defined herein.

Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.

Abstract: A battery charger controller is configured to add a compensation current in the feedback control loop such that the output voltage varies with the output current to compensate charging cable voltage drop. In some embodiments, the output voltage is also proportional to a compensation resistor. Therefore, cable voltage drop compensation can be adjusted using a resistor that is external to the controller IC. The external resistor may be one of the feedback resistors connected at a voltage feedback pin. In another embodiment, the adjustable resistor is the resistor between the feedback resistors and the voltage feedback pin. In still another embodiment, the adjustable resistor is the resistor in parallel with a compensation capacitor. In embodiments of the invention, adjusting the resistance of the external compensation resistor can change the voltage drop compensation and allow the power supply to meet requirements of different charging cable applications.

Abstract: Provided herein are Heteroaryl Compounds having the following structure: wherein R1-R4 are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, neurodegenerative diseases, diabetes, obesity, neurological disorders, age-related diseases, or cardiovascular conditions, comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.